Literature DB >> 27084233

Blinded search for varicella zoster virus in giant cell arteritis (GCA)-positive and GCA-negative temporal arteries.

Don Gilden1, Teresa White2, Nelly Khmeleva2, Bradley J Katz3, Maria A Nagel2.   

Abstract

Recent analysis of archived temporal arteries (TAs) acquired from 13 pathology laboratories in the US, Canada, Iceland, France, Germany and Israel from patients with pathologically-verified giant cell arteritis (GCA-positive) and TAs from patients with clinical features and laboratory abnormalities of GCA but whose TAs were pathologically negative (GCA-negative) revealed VZV antigen in most TAs from both groups. Despite formalin-fixation, VZV DNA was also found in many VZV-antigen positive sections that were scraped, subjected to DNA extraction, and examined by PCR with VZV-specific primers. Importantly, in past studies, the pathological diagnosis (GCA-positive or -negative) was known to the neurovirology laboratory. Herein, GCA-positive and GCA-negative TAs were provided by an outside institution and examined by 4 investigators blinded to the pathological diagnoses. VZV antigen was found in 3/3 GCA-positive TAs and in 4/6 GCA-negative TAs, and VZV DNA in 1/3 VZV antigen-positive, GCA-positive TAs and in 3/4 VZV antigen-positive, GCA-negative TAs. VZV DNA was also detected in one GCA-negative, VZV-antigen negative TA. Overall, the detection of VZV antigen in 78% of GCA-positive and GCA-negative TAs is consistent with previous reports on the prevalence of VZV antigen in patients with clinically suspect GCA.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Giant cell arteritis; Varicella zoster virus

Mesh:

Substances:

Year:  2016        PMID: 27084233      PMCID: PMC4834150          DOI: 10.1016/j.jns.2016.03.020

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

1.  Association of varicella zoster virus with giant cell arteritis.

Authors:  Don Gilden
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2014-06-03

2.  Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis.

Authors:  Don Gilden; Teresa White; Nelly Khmeleva; Anna Heintzman; Alexander Choe; Philip J Boyer; Charles Grose; John E Carpenter; April Rempel; Nathan Bos; Balasubramaniyam Kandasamy; Kelly Lear-Kaul; Dawn B Holmes; Jeffrey L Bennett; Randall J Cohrs; Ravi Mahalingam; Naresh Mandava; Charles G Eberhart; Brian Bockelman; Robert J Poppiti; Madhura A Tamhankar; Franz Fogt; Malena Amato; Edward Wood; Vikram Durairaj; Steve Rasmussen; Vigdis Petursdottir; Lea Pollak; Sonia Mendlovic; Denis Chatelain; Kathy Keyvani; Wolfgang Brueck; Maria A Nagel
Journal:  Neurology       Date:  2015-02-18       Impact factor: 9.910

3.  Varicella Zoster Virus in Temporal Arteries of Patients With Giant Cell Arteritis.

Authors:  Don Gilden; Maria Nagel
Journal:  J Infect Dis       Date:  2015-07-15       Impact factor: 5.226

4.  Multifocal VZV vasculopathy with temporal artery infection mimics giant cell arteritis.

Authors:  Maria A Nagel; Jeffrey L Bennett; Nelly Khmeleva; Alexander Choe; April Rempel; Philip J Boyer; Don Gilden
Journal:  Neurology       Date:  2013-05-01       Impact factor: 9.910

5.  Analysis of Varicella-Zoster Virus in Temporal Arteries Biopsy Positive and Negative for Giant Cell Arteritis.

Authors:  Maria A Nagel; Teresa White; Nelly Khmeleva; April Rempel; Philip J Boyer; Jeffrey L Bennett; Andrea Haller; Kelly Lear-Kaul; Balasurbramaniyam Kandasmy; Malena Amato; Edward Wood; Vikram Durairaj; Franz Fogt; Madhura A Tamhankar; Hans E Grossniklaus; Robert J Poppiti; Brian Bockelman; Kathy Keyvani; Lea Pollak; Sonia Mendlovic; Mary Fowkes; Charles G Eberhart; Mathias Buttmann; Klaus V Toyka; Tobias Meyer-ter-Vehn; Vigdis Petursdottir; Don Gilden
Journal:  JAMA Neurol       Date:  2015-11       Impact factor: 18.302

  5 in total
  9 in total

Review 1.  Varicella Zoster Virus in Giant Cell Arteritis: A Review of Current Medical Literature.

Authors:  Rochella A Ostrowski; Sheela Metgud; Rodney Tehrani; Walter M Jay
Journal:  Neuroophthalmology       Date:  2019-07-02

Review 2.  Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future?

Authors:  Anne A Gershon
Journal:  J Infect       Date:  2017-06       Impact factor: 6.072

3.  Herpes Zoster as a Risk Factor for Incident Giant Cell Arteritis.

Authors:  Bryant R England; Ted R Mikuls; Fenglong Xie; Shuo Yang; Lang Chen; Jeffrey R Curtis
Journal:  Arthritis Rheumatol       Date:  2017-11-09       Impact factor: 10.995

Review 4.  The microbiome in autoimmune rheumatic disease.

Authors:  Maximilian F Konig
Journal:  Best Pract Res Clin Rheumatol       Date:  2020-02-07       Impact factor: 4.098

Review 5.  Mechanism and biomarkers in aortitis--a review.

Authors:  Benjamin Benhuri; Ammar ELJack; Bashar Kahaleh; Ritu Chakravarti
Journal:  J Mol Med (Berl)       Date:  2019-10-30       Impact factor: 4.599

6.  Bioinformatic analysis reveals new determinants of antigenic 14-3-3 proteins and a novel antifungal strategy.

Authors:  Jenna E McGowan; Jacqueline Kratch; Saurabh Chattopadhyay; Bina Joe; Heather R Conti; Ritu Chakravarti
Journal:  PLoS One       Date:  2017-12-12       Impact factor: 3.240

7.  Identification of Herpes Zoster-Associated Temporal Arteritis Among Cases of Giant Cell Arteritis.

Authors:  Erin M Buckingham; Maria A Foley; Charles Grose; Nasreen A Syed; Morton E Smith; Todd P Margolis; Matthew J Thurtell; Randy Kardon
Journal:  Am J Ophthalmol       Date:  2017-12-30       Impact factor: 5.258

8.  Does herpes zoster predispose to giant cell arteritis: a geo-epidemiologic study.

Authors:  Edsel B Ing; Royce Ing; Xinyang Liu; Angela Zhang; Nurhan Torun; Michael Sey; Christian Pagnoux
Journal:  Clin Ophthalmol       Date:  2018-01-11

Review 9.  Profile of tocilizumab and its potential in the treatment of giant cell arteritis.

Authors:  Susan Patricia Mollan; John Horsburgh; Bhaskar Dasgupta
Journal:  Eye Brain       Date:  2018-01-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.